Methods of identifying agents which inhibit GPR-9-6

Details Methods of identifying agents which inhibit GPR-9-6 Methods of identifying agents which inhibit GPR-9-6

2005-04-26

2005-04-26

Nolan, Patrick J. (Department: 1644)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S006120, C435S007100

Reexamination Certificate

active

06884574

ABSTRACT:
The invention relates to an antibody or antigen-binding fragment thereof which binds to the CC chemokine receptor GPR-9-6 and blocks the binding of a ligand (e.g., TECK) to the receptor. The invention also relates to a method of identifying agents (molecules, compounds) which can bind to GPR-9-6 and inhibit the binding of a ligand (e.g., TECK) and/or modulate a function of GPR-9-6. The invention further relates to a method of modulating a function of GPR-9-6, and to the use of the antibodies, antigen-binding fragments and agents identified by the method of the invention in research, therapeutic, prophylactic and diagnostic methods.

REFERENCES:
patent: 5440021 (1995-08-01), Chuntharapai et al.
patent: 5652133 (1997-07-01), Murphy
patent: 6329159 (2001-12-01), Andrew et al.
patent: 6503735 (2003-01-01), Wei et al.
patent: WO 9748807 (1997-12-01), None
patent: WO 9801557 (1998-01-01), None
patent: WO 9832858 (1998-07-01), None
MOLT-13, ACC 436 [online] Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, 2004, [retrieved on Jun. 10, 2004]. Retrieved from the Internet: <URL: www.dsmz.de/mutz/mutz436.htm.
Huang,Z., “Structural Chemistry and Therapeutic Intervention of Protein-Protein Interactions in Immune Response, Human Immunodeficiency Virus Entry, and Apoptosis,”Pharmacology&Therapeutics, 86: 201-215 (2000).
Zlotnick, A., and Yoshie, O., “Chemokines: A New Classification System and Their Role in Immunity,”Immunity, 12(2): 121-127 (2000).
Mackay, C.R., “Chemokines: Immunology's High Impact Factors,”Nature Immunology, 2(2): 95-101 (2001).
ATCC Accession No. CRL-1582, “MOLT-4”, In:Catalogue of ATCC Cell Lines and Hybridomas,7th Edition, (Rockville, MD: American Type Culture Collection), p. 149 (1992).
Yoshida, R., et al., “Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That is a Specific Functional Ligand for EBI1, CCR7,”J. Biol. Chem., 272(21):13803-13809 (1997).
Baba, M., et al., “Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC,”J. Biol. Chem., 272(23): 14893-14898 (1997).
Imai, T., et al., “The T Cell-directed CC Chemokine TARC is a Highly Specific Biological Ligand for CC Chemokine Receptor 4,”J. Biol. Chem., 272(23):15036-15042 (1997).
Kitaura, M., et al., “Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3,”J. Biol. Chem., 271(13):7725-7730 (1996).
Vicari, A.P., et al., “TECK: A Novel CC Chemokine Specifically Expressed by Thymic Dendritic Cells and Potentially Involved in T Cell Development,”Immunity, 7:291-301 (1997).
Damon, I., et al., “Broad Spectrum Chemokine Antagonistic Activity of a Human Poxvirus Chemokine Homolog,”Proc. Natl. Acad. Sci. USA, 95: 6403-6407 (1998).
O'Garra A., et al., “T-Cell Subsets: Chemokine Receptors Guide the Way,”Current Biology, 8:R646-R649 (1998).
Kim, C.H., et al., “Chemokines: Signal Lamps for Trafficking of T and B Cells for Development of Effector Function,”J. Leukoc. Biol., 65: 6-15 (1999).
Murphy, P.M., “The Molecular Biology of Leukocyte Chemoattractant Receptors,”Annu. Rev. Immunol., 12:593-633 (1994).
Zlotnik, A., et al., “Recent Advances in Chemokines and Chemokine Receptors,”Critical Reviews™ in Immunology, 19:1-47 (1999).
Nomiyama, H., et al., “The Human CC Chemokine TECK (SCYA25) Maps to Chromosome 19p13.2,”Genomics, 51:311-312 (1998).
Vicari, A.P., et al., “TECK: A Novel CC Chemokine Associated with T-Cell Development,”J. Allergy Clin. Immunol., 99(1):S246, Abstract No. 1003, (1997).
Combadiere, C., et al., “Cloning and Functional Expression of Two Human CC Chemokine Receptors,”FASEB J., 10(6):A1093, Abstract No. 545 (1996).
Gao, J.-L., et al., “Cloning and Expression of the Mouse MIP1-1α Receptor Gene and Two Related Genes,”9th International Congress of Immunology,p. 108, Abstract No. 637 (1995).
GenBank Accession No. US45982, “Human G Protein Coupled Receptor GPR-9-6 Gene, Complete CDS,” (1996).
Zaballos, A., et al., “Cutting Edge: Identification fo the Orphan Chemokine Receptor GPR-9-6 as CCR9, the Receptor for the Chemokine TECK,”J. Immunol., 162(10):5671-5675 (1999).
Chuntharapai, A. and Kim, K.J., “Generation of Monoclonal Antibodies to Chemokine Receptors,”Methods of Enzymology, 288:15-27 (1997).
Locati, M., et al., “Chemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDS,”Annu. Rev. Med., 50:425-440 (1999).
Zabel, B.A., et al., Human G Protein-coupled Receptor GPR-9-6/CC Chemokine Receptor 9 is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and is Required for Thymus-expressed Chemokine-mediated Chemotaxis,J. Exp. Med., 190(9):1241-1255 (1999).
Swissprot Database, Accession No. P51686, “Probable G-Protein-Coupled Receptor GPR-9-6” [online], Oct. 1996.
Nibbs, R.J.B., et al., “Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6,”J. Biol. Chem., 272(51): 32078-32083 (1997).
Murphy, P.M., et al., “International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors,”Pharmacol. Rev., 52(1):145-176 (2000).
Youn, B-S, et al., “TECK, an Efficacious Chemoattractant for Human Thymocytes, Uses GPR-9-6/CCR9 as a Specific Receptor,”Blood, 94(7):2533-2536 (1999).
Attwood, T.K., “The Babel of Bioinformatics,”Science, 290:471-473.

Affiliated with

Also associated with

Rating

Methods of identifying agents which inhibit GPR-9-6 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of identifying agents which inhibit GPR-9-6, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying agents which inhibit GPR-9-6 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3411653